2021
DOI: 10.1002/slct.202004711
|View full text |Cite
|
Sign up to set email alerts
|

Development and Characterization of Montmorillonite‐Based Hybrid Materials for pH‐Responsive Drug Delivery

Abstract: This study reports the development of montmorillonite (MMT)‐based hybrid systems for pH‐responsive drug delivery. During fabrication, MMT is first modified with dimethyl sulfoxide (DMSO) and methanol (MeOH), with the generated hybrid materials being designated as MMTDMSO and MMTMeOH, respectively. The hybrid materials are then intercalated with DOX for drug delivery purposes. Results of XRD and DSC reveal that DOX is successfully intercalated into the MMT interlayers. In vitrodrug release studies of the DOX‐lo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…The safety, bioavailability and target specificity are some of the factors to be considered when astragaloside IV-based regimens are adopted to tackle neuronal aging. Nevertheless, with the advances in nanotechnologies [ 167 , 168 , 183 ], some of the problems (including the low bioavailability and lack of target specificity) associated with the therapeutic use of astragaloside IV should be able to be addressed. Last but not least, till now most of the studies on the biological activity of astragaloside IV are performed in vitro or in vivo , studies examining the therapeutic effect of the agent in the clinical context is lacking.…”
Section: Discussionmentioning
confidence: 99%
“…The safety, bioavailability and target specificity are some of the factors to be considered when astragaloside IV-based regimens are adopted to tackle neuronal aging. Nevertheless, with the advances in nanotechnologies [ 167 , 168 , 183 ], some of the problems (including the low bioavailability and lack of target specificity) associated with the therapeutic use of astragaloside IV should be able to be addressed. Last but not least, till now most of the studies on the biological activity of astragaloside IV are performed in vitro or in vivo , studies examining the therapeutic effect of the agent in the clinical context is lacking.…”
Section: Discussionmentioning
confidence: 99%
“…Due to the strong interaction between clay minerals and drug molecules, which results in high adsorption rates and a slow drug release rate, clay minerals are considered a possible choice for controlled drug release. So, clay minerals are becoming more and more useful in biomedical fields like drug delivery and regenerative medicine [11].…”
Section: Introductionmentioning
confidence: 99%